300858 科拓生物
按盤價 
15.280 +0.840 (+5.817%)
15.280 +0.840 (+5.817%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.508 | 5.451 | 8.250 | 11.531 | 14.496 |
| 總資產報酬率 ROA (%) | 2.398 | 5.191 | 7.760 | 10.739 | 13.183 |
| 投入資產回報率 ROIC (%) | 2.470 | 5.361 | 8.085 | 11.344 | 14.451 | 邊際利潤分析 |
| 銷售毛利率 (%) | 54.979 | 54.582 | 51.975 | 50.313 | 48.321 |
| 營業利潤率 (%) | 36.316 | 34.287 | 34.558 | 34.201 | 34.707 |
| 息稅前利潤/營業總收入 (%) | 26.872 | 26.262 | 33.175 | 32.338 | 32.349 |
| 淨利潤/營業總收入 (%) | 31.521 | 31.239 | 29.767 | 30.042 | 28.475 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 82.182 | 87.848 | 89.411 | 77.507 | 94.004 |
| 價值變動淨收益/利潤總額(%) | 5.513 | 7.237 | 7.433 | 10.599 | 2.979 |
| 營業外收支淨額/利潤總額(%) | -0.114 | -0.549 | -1.529 | -0.427 | -4.007 | 償債能力分析 |
| 流動比率 (X) | 12.853 | 16.296 | 15.560 | 12.046 | 11.907 |
| 速動比率 (X) | 12.337 | 15.627 | 14.963 | 11.200 | 11.212 |
| 資產負債率 (%) | 4.473 | 4.259 | 5.308 | 7.046 | 0.067 |
| 帶息債務/全部投入資本 (%) | 0.395 | 0.737 | 0.966 | 1.715 | 0.113 |
| 股東權益/帶息債務 (%) | 25,027.637 | 13,323.437 | 10,189.120 | 5,668.954 | 88,464.610 |
| 股東權益/負債合計 (%) | 2,135.589 | 2,247.741 | 1,783.798 | 1,319.193 | 1,399.050 |
| 利息保障倍數 (X) | -2.858 | -3.350 | -38.431 | -18.825 | -31.703 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 78.985 | 101.453 | 106.466 | 115.992 | 118.013 |
| 存貨周轉天數 (天) | 106.904 | 119.403 | 105.367 | 96.953 | 76.926 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
